From Surf Wiki (app.surf) — the open knowledge base
Norfenefrine
Sympathomimetic drug
Sympathomimetic drug
| Field | Value | |||
|---|---|---|---|---|
| Verifiedfields | changed | |||
| verifiedrevid | 462263073 | |||
| image | Norfenefrine.png | |||
| image_class | skin-invert-image | |||
| width | 200px | |||
| image2 | (R)-Norfenefrine molecule ball.png | |||
| image_class2 | bg-transparent | |||
| width2 | 200px | |||
| alt2 | Ball-and-stick model of (R)-Norfenefrine | |||
| Drugs.com | ||||
| legal_status | Rx-only | |||
| metabolism | m-Hydroxymandelic acid | |||
| CAS_number_Ref | ||||
| CAS_number | 536-21-0 | |||
| CAS_supplemental | ||||
| 15308-34-6 (hydrochloride) | ||||
| ATC_prefix | C01 | |||
| ATC_suffix | CA05 | |||
| PubChem | 4538 | |||
| ChemSpiderID_Ref | ||||
| ChemSpiderID | 4379 | |||
| UNII_Ref | ||||
| UNII | D2P3M6SRN5 | |||
| KEGG_Ref | ||||
| KEGG | D08286 | |||
| ChEBI | 134779 | |||
| ChEMBL_Ref | ||||
| ChEMBL | 358040 | |||
| DrugBank | DB13378 | |||
| synonyms | Norfenephrine; Norphenephrine; Norphenylephrine; meta-Norsynephrine; meta-Octopamine; 3-Octopamine; Adrianol; 3,β-Dihydroxyphenethylamine; 3,β-Dihydroxy-β-phenylethylamine | |||
| IUPAC_name | 3-(2-Amino-1-hydroxyethyl)phenol | |||
| C | 8 | H=11 | N=1 | O=2 |
| SMILES | OC(c1cc(O)ccc1)CN | |||
| StdInChI_Ref | ||||
| StdInChI | 1S/C8H11NO2/c9-5-8(11)6-2-1-3-7(10)4-6/h1-4,8,10-11H,5,9H2 | |||
| StdInChIKey_Ref | ||||
| StdInChIKey | LRCXRAABFLIVAI-UHFFFAOYSA-N |
| Drugs.com =
| elimination_half-life =
15308-34-6 (hydrochloride)
Norfenefrine, also known as meta-octopamine or norphenylephrine and sold under the brand name Novadral among others, is a sympathomimetic medication which is used in the treatment of hypotension (low blood pressure). Along with its structural isomer p-octopamine and the tyramines, norfenefrine is a naturally occurring endogenous trace amine and plays a role as a minor neurotransmitter in the brain.
Medical uses
Norfenefrine is used in the treatment of hypotension (low blood pressure). It is said to be similarly effective or less effective than midodrine.
Pharmacology
Pharmacodynamics
Norfenefrine is described as an α-adrenergic receptor agonist and sympathomimetic agent. It is said to act predominantly as an α1-adrenergic receptor agonist.
Chemistry
Norfenefrine, also known as 3,β-dihydroxyphenethylamine, is a substituted phenethylamine derivative. It is an analogue of norepinephrine (3,4,β-trihydroxyphenethylamine), of meta-tyramine (3-hydroxyphenethylamine), of phenylephrine ((R)-β,3-dihydroxy-N-methylphenethylamine), of etilefrine (3,β-dihydroxy-N-ethylphenethylamine), and of metaterol (3,β-dihydroxy-N-isopropylphenethylamine), as well as of metaraminol ((1R,2S)-3,β-dihydroxy-α-methylphenethylamine).
Norfenefrine is used medically as the hydrochloride salt.
The predicted log P of norfenefrine is -0.28 to -0.95.
Society and culture
Names
Norfenefrine is the generic name of the drug and its . Synonyms of norfenefrine include hydroxyphenylethanolamine, nor-phenylephrine, and m-norsynephrine, among others. Brand names of norfenefrine include Novadral, A.S. COR, Coritat, Energona, Hypolind, Norfenefrin Ziethen, and Norfenefrin-Ratiopharm, among others.
Availability
Norfenefrine is marketed in Europe, Japan, and Mexico.
References
References
- (1974). "The physiological disposition of p-octopamine in man". Naunyn-Schmiedeberg's Archives of Pharmacology.
- Elks, J.. (2014). "The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies". Springer US.
- Macdonald F. (1997). "Dictionary of Pharmacological Agents". CRC Press.
- (2000). "Index Nominum 2000: International Drug Directory". Taylor & Francis.
- (December 1977). "m-Octopamine, p-octopamine and phenylethanolamine in rat brain: a sensitive, specific assay and the effects of some drugs". Journal of Neurochemistry.
- (November 1989). "Midodrine. A review of its pharmacological properties and therapeutic use in orthostatic hypotension and secondary hypotensive disorders". Drugs.
- (January 1998). "Midodrine. A review of its therapeutic use in the management of orthostatic hypotension". Drugs Aging.
- (March 2007). "Orthostatic hypotension: evaluation and treatment". Cardiovasc Hematol Disord Drug Targets.
- (June 2008). "Pharmacology of stimulants prohibited by the World Anti-Doping Agency (WADA)". Br J Pharmacol.
- "Norfenefrine".
- (23 June 2017). "Norfenefrine: Uses, Interactions, Mechanism of Action".
- (31 August 2024). "norfenefrine".
This article was imported from Wikipedia and is available under the Creative Commons Attribution-ShareAlike 4.0 License. Content has been adapted to SurfDoc format. Original contributors can be found on the article history page.
Ask Mako anything about Norfenefrine — get instant answers, deeper analysis, and related topics.
Research with MakoFree with your Surf account
Create a free account to save articles, ask Mako questions, and organize your research.
Sign up freeThis content may have been generated or modified by AI. CloudSurf Software LLC is not responsible for the accuracy, completeness, or reliability of AI-generated content. Always verify important information from primary sources.
Report